Shares of Pfizer Inc. suffered their biggest monthly decline since 2009 in January As investors anticipated a troubled path ahead for the drugmaker’s Covid products. Tweet on Pfizer stock Shares of @pfizer sufferedRead More
Shares of Eli Lilly were down midday Friday after the company said U.S. regulators rejected its proposed new Alzheimer’s disease treatment! The U.S. Food and Drug Administration said it needed more data fromRead More
Biotech Stock skyrocketed today after the trial result announcement ! It’s a big momentum for all shareholders of tiny Kala Pharmaceuticals. Tweet on Kala Pharmaceuticals Biotech Stock skyrocketed today after the trial resultRead More
Madrigal Pharmaceuticals shares jumped over 200% in morning trading! Market reacted after the company said it say “positive topline results” from a late-stage clinical trial of resmetirom, a treatment for liver conditions. TweetRead More
Shares in Abiomed jumped by half after Johnson & Johnson announcement! J&J announced that it would buy the heart, lung and kidney treatment company in a deal with an initial enterprise value overRead More
Biogen.inc, raised its outlook for profits and revenue on Tuesday as investors await full results of the Alzheimer’s drug, ‘lecanemab’ Japan-based pharmaceutical firm Eisai (ticker: ESALY) and Biogen (BIIB) last month said theRead More
Shares of Moderna surged more than 12% on Wednesday! That due to the news that the biotech company announced it would soon develop and sell a personalized cancer vaccine with Merck. The stockRead More
Biogen shares surged some 37% in afternoon trading! That happened after the company said its experimental Alzheimer’s drug had significantly slowed the disease’s progression in a large study, Biogen reports Tweet on theRead More
Moderna sues Pfizer Inc. and BioNTech SE! Moderna says rivals copied its methods for encoding genetic material and used the same chemical modification in their Covid-19 vaccine! Moderna filed a lawsuit in aRead More
Pfizer will sell to the United Nations Children’s Fund up to four million treatment courses of Paxlovid! exclusively for use in low- and middle-income countries, Unicef confirms Pfizer Inc. plans to sell toRead More
